EP3383397
LYFJASAMSETNINGAR SEM INNIHALDA DÓRAVÍRÍN, TENÓFÓVÍR TVÍSÓPROXÍL FÚMARAT OG LAMIVÚDÍN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.11.2016EP published:
22.9.2021EP application number:
16871332.9
EP translation filed:
15.11.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
28.11.2036Expiry date:
28.11.2026Next due date:
30.11.2026
Title:
PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE
Timeline
Today
29.11.2016EP application
22.9.2021EP Publication
15.11.2021Translation submitted
15.12.2021Registration published
28.11.2026Expires
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Inventor
Name:
PANMAI, SantipharpAddress:
Rahway New Jersey 07064-0907, US
Name:
TATAVARTI, AdityaAddress:
West Point Pennsylvania 19486, US
Name:
FARRINGTON, Andrew, M.Address:
West Point Pennsylvania 19486, US
Name:
BIYYALA, VarshaAddress:
Rahway New Jersey 07065-0907, US
Name:
ALLAIN, Leonardo, R.Address:
West Point Pennsylvania 19486, US
Name:
NEFLIU, MarcelaAddress:
West Point Pennsylvania 19486, US
Name:
KLINZING, Gerard, R.Address:
West Point Pennsylvania 19486, US
Name:
REN, JieAddress:
West Point Pennsylvania 19486, US
Name:
LAMM, MatthewAddress:
Rahway New Jersey 07065-0907, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562261953 PDate:
2.12.2015Country:
US
Classification
Categories:
A61K 9/24, A61K 9/14, A61K 31/4412, A61K 31/513, A61K 31/683, A61P 31/18, A61K 9/16
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 22.10.2021
Expires: 28.11.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 12.10.2022
Expires: 28.11.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 6.11.2023
Expires: 28.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 15.10.2024
Expires: 28.11.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.11.2025
Expires: 28.11.2026
Payer: Árnason Faktor ehf.